JPRN-UMIN000017674已完成未知
Phase I study of irinotecan, S-1 and oxaliplatin in combination with radiation therapy in patients with advanced rectal cancer - Phase I study of irinotecan, S-1 and oxaliplatin in combination with radiation therapy in patients with advanced rectal cancer
Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine0 个研究点目标入组 12 人开始时间: 2015年5月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Previous history of drug-induced allergy 2)Pregnant of lactating and woman with childbearing potential who lacked effective contaception 3)Man who lacked effective contraception 4)With uncontrolled renal failure 5)With uncontrolled heart disease 6)With severe plumonary disease 7)With gastrointestinal bleeding, obstruction, perforation 8)With active inflammatory bowel disease 9)With active infection 10)With large amount of ascites, pleural effusion, or pericardial effusion 11)Any other cases who are regarded as inadequate for study enrollment by the investigator
研究者
相似试验
招募中
1 期
Phase I study of S-1, irinotecan plus oxaliplatin combination therapy (S-IROX) for advanced pancreatic cancerpancreatic cancerJPRN-UMIN000012054ational Cancer Center Hospital24
招募中
不适用
Phase I/II study of S-1, irinotecan plus oxaliplatin combination therapy (SOXIRI) for advanced pancreatic cancer(KANAPS 06 study)advanced pancreatic cancerJPRN-UMIN000014339KANAPS(Kansai and Nara Pancreatobiliary Study group)53
已完成
1 期
PhaseI/II study of irinotecan and oxaliplatin combination chemotherapy in patients with gemcitabine and 5-fluorouracil refractory pancreatic cancer.pancreatic cancerJPRN-UMIN000015877Chiba cancer center30
进行中（未招募）
2 期
Phase2 trial of oxaliplatin, irinotecan and S-1 (OX-IRIS) as first line chemotherapy for unresectable pancreatic cancerpancreatic cancerJPRN-jRCTs011190008Komatsu Yoshito40
已完成
2 期
A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric CancerStomach NeoplasmsNCT00512681National Cancer Center, Korea44